Skip to main content

Ambrose Kristen's Form 4 filing

Vertex Pharmaceuticals Inc (VRTX) · filed Feb 28, 2023

Accession no.
0001209191-23-013695
Filed
Feb 28, 2023
Trade date
Feb 24-27, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions. Open-market sales total $347.1K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ambrose KristenCIK 0001856587Officer (SVP & Chief Accounting Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 24, 2023Common StockFTax withholdingDisposed−502$289.12−$145,138.248,510Direct
Feb 27, 2023Common StockSSaleDisposed−982$287.25F2,F3−$282,079.57,528Direct
Feb 27, 2023Common StockSSaleDisposed−183$288.68F2,F4−$52,828.447,345Direct
Feb 27, 2023Common StockSSaleDisposed−42$289.63−$12,164.467,303Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Referenced by the price of 2 transactions in Table I.

F3

Open market sales reported on this line occurred at a weighted average price of $287.25 (range $286.79 to $287.71).

Referenced by the price of 1 transaction in Table I.

F4

Open market sales reported on this line occurred at a weighted average price of $288.68 (range $288.24 to $289.17).

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)